α-Substituted glycinamide derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458092
APP PUB NO 20160115119A1
SERIAL NO

14889475

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is to provide a novel α-substituted glycinamide derivative, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KISSEI PHARMACEUTICAL CO LTD19-48 YOSHINO MATSUMOTO-SHI NAGANO 3998710 ?3998710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hirasawa, Hideaki Azumino, JP 13 50
Kawamura, Naohiro Joetsu, JP 7 109
Kobayashi, Junichi Azumino, JP 164 4012

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00